These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16323566)

  • 21. [Pathogenetic aspects of the development of cholelithiasis in patients with metabolic syndrome].
    Uspenskiy YP; Fominykh YA; Nadzhafova KN; Vovk AV; Koshcheev AV
    Ter Arkh; 2021 Feb; 93(2):209-214. PubMed ID: 36286639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
    Mansilla E; Díaz Aquino V; Zambón D; Marin GH; Mártire K; Roque G; Ichim T; Riordan NH; Patel A; Sturla F; Larsen G; Spretz R; Núñez L; Soratti C; Ibar R; van Leeuwen M; Tau JM; Drago H; Maceira A
    Stem Cells Int; 2011; 2011():943216. PubMed ID: 21716667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.
    Zirlik A; Leugers A; Lohrmann J; Ernst S; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2004 Apr; 91(4):674-82. PubMed ID: 15045127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin resistance: the adipose tissue in the focus].
    Urich E
    Orv Hetil; 2005 Oct; 146(43):2199-207. PubMed ID: 16323566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
    Saraf N; Sharma PK; Mondal SC; Garg VK; Singh AK
    J Pharm Pharmacol; 2012 Feb; 64(2):161-71. PubMed ID: 22221092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinediones.
    Yki-Järvinen H
    N Engl J Med; 2004 Sep; 351(11):1106-18. PubMed ID: 15356308
    [No Abstract]   [Full Text] [Related]  

  • 28. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
    Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinediones and type 2 diabetes: from cellular targets to cardiovascular benefit.
    Papaetis GS; Orphanidou D; Panagiotou TN
    Curr Drug Targets; 2011 Sep; 12(10):1498-512. PubMed ID: 21675944
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.